Compare Vital Farms Inc (VITL) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vital Farms Inc vs Zimmer Biomet Holdings Inc — how do they compare? Vital Farms Inc trades at $9.33 (market cap $405.27M), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 41.8× Vital Farms Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vital Farms Inc for 14 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| VITL | ZBH | |
|---|---|---|
Market Cap | $405.27M | $16.95B |
Volume | 1,810,837 | 2,505,240 |
Sector | Consumer Staples | Health |
52-Week High | $43.68 | $103.98 |
52-Week Low | $8.28 | $79.58 |
Typical Hold Time | 14 Days | 89 Days |
Enterprise Value | $492.28M | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vital Farms (VITL) trades at $9.33, showing modest daily gains but facing significant fundamental challenges. The company reported declining revenue and profitability in 2026, with net income margin collapsing to 0.02% from 8.72% in 2025. Technical indicators show bearish momentum, while analyst sentiment remains cautiously optimistic with a $13.11 consensus target. Recent news highlights strategic review possibilities and institutional accumulation despite operational headwinds.
The outlook remains challenging with pricing pressure and supply issues affecting margins, though strategic options exploration provides potential upside. Investment opportunity exists if operational improvements materialize, but risks include sustained margin compression and execution challenges in a competitive egg market.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
